Boxer Capital, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2017$41,200,000
-12.0%
500,0000.0%9.38%
-15.8%
Q2 2017$46,815,000
-26.5%
500,000
-50.0%
11.13%
-20.0%
Q1 2017$63,670,000
+68.6%
1,000,000
+17.6%
13.91%
-4.7%
Q4 2016$37,757,000
+4.7%
850,000
-15.0%
14.60%
-9.6%
Q3 2016$36,050,000
+483.9%
1,000,000
+122.2%
16.16%
+195.2%
Q2 2016$6,174,000450,0005.47%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 407,416$14,259,560,0008.34%
Palo Alto Investors LP 3,547,719$124,170,0006.91%
Antipodean Advisors LLC 1,268,658$44,403,0006.48%
Redmile Group, LLC 1,795,936$62,858,0004.70%
HealthCor Management, L.P. 1,525,000$53,375,0003.24%
PointState Capital LP 3,503,900$122,637,0003.12%
NEA Management Company, LLC 1,139,890$39,896,0002.54%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 612,500$21,438,0002.44%
PFM Health Sciences, LP 2,078,440$72,745,0002.21%
Partner Investment Management, L.P. 35,300$1,236,0002.03%
View complete list of CLOVIS ONCOLOGY INC shareholders